🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

JeeSuk Chang Thank you so much for having me. I was so impressed by the high calibre of patient care and research here, as well as the heavy ion therapy center. See you again soon!

ViewRay® Files Voluntary Chapter 11 Petitions This was not good news to wake up to for the week. ViewRay has changed radiation oncology and I am optimistic that they will be able to restructure and continue to grow. 1/2 prnewswire.com/news-releases/… prnewswire.com/news-releases/…

Adaptive is to Viewray as arc therapy was to Tomotherapy and SBRT was to Cyberknife. These advancements have, IMO, made rad oncs think differently about RT delivery and, in total, made the field better for our patients. Innovation is always risky however 2/2

AAPM 2023 in Houston. Part of UTSW team.

Feeling incredibly fortunate to have such amazing and supportive advisors by my side. Had a great time catching up with them at #AAPM2023! 🙌😊 Jinsung Harini Veeraraghavan

It's a great honor to join the podcast!

The prospective data for unfavorable intermediate risk and high risk are truly impressive and suggests a biological enhancement effect with proton therapy that matches preclinical data suggesting an RBE up to 1.5. A randomized superiority trial may be best in these patients.

NEJM article RT in luminal A breast cancer nejm.org/doi/full/10.10… "However, RT is inconvenient, costly, and associated with both short-term and long-term side effects." ❓ Evidence of this statement 👉 Estimation of patient effort RT vs tamoxifen: about 10h vs 30h #RadOnc

NICE approval of AI technology for radiotherapy contour planning!!! thelancet.com/journals/lanon…

I am pleased with the strong turnout today from all aspects of radiotherapy care and delivery for our x-ray guided, adaptive symposium. The content was fabulous with thoughtful speakers sharing experience.

Rad onc = #1 for professional fulfillment 🙌🏽

sdfsdfsdf

We use a similar approach to Chad Tang, MD in Peter Mac Radiation Oncology GU Cast | Urology podcast! #radonc. We often use SABR alone upfront in oligometastases. We reported a 3- and 5-year freedom from systemic therapy of 40% and 31% with this approach here (n=401, basket histology); shorturl.at/kpqwV

Amazing 3 day workshop with Elekta optimizing breath-hold continuous motion gating for kidney cancer at MD Anderson Cancer Center with Michael Saracen and Jinzhong Yang . Got to get my kidney "treated" during the workshop and gained appreciation for what patients experience.

Actinium-225 quantification and SPECT/CT reconstruction (ACTI-QUANT) Grand Challenge: AAPM is sponsoring a Challenge on the evaluation of SPECT/CT reconstruction quantification accuracy with the Actinium-255 isotope. The two top-performing teams (one… aapm.org/GrandChallenge…

When you’re constantly reviewing radiotherapy isodose distributions on large computer screens it’s easy to lose sight of just how amazingly accurate linacs are. We can deliver ablative doses of radiation with mm accuracy! Here are a list of other things that are 1 mm in size

Registration for our ART Symposium is now open! Explore the latest in adaptive radiation therapy, from current clinical applications to AI-driven innovations. Open to radiation oncologists, physicists, dosimetrists, therapists, and more. Register here ➡️: bit.ly/40XbQiN

Congratulations to Dr. Steve Jiang on being named the David A. Pistenmaa, M.D., Ph.D., Distinguished Chair in Radiation Oncology! This honor recognizes his groundbreaking work and supports his Medical Artificial Intelligence and Automation Lab initiatives, continuing Dr. Pistenmaa's legacy in the field.